Working… Menu
Trial record 1 of 1 for:    NCT01446744
Previous Study | Return to List | Next Study

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) (SABR-COMET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01446744
Recruitment Status : Active, not recruiting
First Posted : October 5, 2011
Last Update Posted : February 26, 2021
London Regional Cancer Program, Canada
VU University of Amsterdam
Information provided by (Responsible Party):
David Palma, Lawson Health Research Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : November 2021